Data / Form D filings / Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc.: Form D filings
Hoth Therapeutics, Inc., a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2017 and 2023. The latest, on January 4, 2023, reports $10 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 ROCKEFELLER PLAZA, SUITE 1039, New York, NY, 10020
- Phone
- (646) 756-2997
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1711786
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | New notice | $10,000,000 | $10,000,000 | 1 | Jan 3, 2023 | sec.gov | |
| Mar 16, 2021 | New notice | $15,000,000 | $15,000,000 | 13 | Mar 10, 2021 | sec.gov | |
| Jan 8, 2021 | New notice | $5,000,000 | $5,000,000 | 3 | Jan 7, 2021 | sec.gov | |
| Aug 21, 2019 | New notice | $5,000,000 | $2,037,120 | $2,962,880 | 53 | Aug 16, 2019 | sec.gov |
| Nov 7, 2017 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 5 | Oct 25, 2017 | sec.gov |
| Jul 14, 2017 | New notice | $675,000 | $675,000 | 1 | Jun 30, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wayne Linsley | Director | |
| David Sarnoff | Director | |
| Robb Knie | Executive Officer, Director | |
| Graig Springer | Director | |
| Jeff Pavell | Director | |
| David Briones | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Hoth Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.